Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.2.3.23 (
GAS
)
957
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The activation of natural killer cells and induction of cytotoxicity are complex processes whose molecular mechanisms have not been clearly elucidated. Stimulation of the
NKL
human NK cell line with interleukin-2 (IL-2) or protein-bound polysaccharide K (PSK) leads to sustained growth and cytolytic activity in comparison to unstimulated
NKL
cells. However, it is not known whether both agents give rise to the same or different intracellular signals. To determine the molecular basis for the action of IL-2 and PSK, the binding activity of AP-1, CRE, NF-kappaB, PU.1, SP-1, NFAT, STAT1, STAT5/6,
GAS
/ISRE and IRF-1 transcription factors was compared in IL-2- and PSK-stimulated
NKL
cells. Here we report that PSK enhanced AP-1 and CRE binding activities, whereas IL-2 increased AP-1 and SP-1 and modified
GAS
/ISRE, IRF-1 and STAT5. Our results indicate that IL-2 and PSK regulate different nuclear transcription factors in
NKL
cells, and that the signal transduction pathway used by these inducers is different.
...
PMID:Protein-bound polysaccharide K and interleukin-2 regulate different nuclear transcription factors in the NKL human natural killer cell line. 1145 71